1. Home
  2. XERS vs BLMN Comparison

XERS vs BLMN Comparison

Compare XERS & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • BLMN
  • Stock Information
  • Founded
  • XERS 2005
  • BLMN 1988
  • Country
  • XERS United States
  • BLMN United States
  • Employees
  • XERS N/A
  • BLMN N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • BLMN Restaurants
  • Sector
  • XERS Health Care
  • BLMN Consumer Discretionary
  • Exchange
  • XERS Nasdaq
  • BLMN Nasdaq
  • Market Cap
  • XERS 628.7M
  • BLMN 714.5M
  • IPO Year
  • XERS 2018
  • BLMN 2012
  • Fundamental
  • Price
  • XERS $4.51
  • BLMN $9.51
  • Analyst Decision
  • XERS Strong Buy
  • BLMN Hold
  • Analyst Count
  • XERS 6
  • BLMN 11
  • Target Price
  • XERS $6.25
  • BLMN $13.25
  • AVG Volume (30 Days)
  • XERS 2.1M
  • BLMN 2.4M
  • Earning Date
  • XERS 08-07-2025
  • BLMN 08-05-2025
  • Dividend Yield
  • XERS N/A
  • BLMN 6.33%
  • EPS Growth
  • XERS N/A
  • BLMN N/A
  • EPS
  • XERS N/A
  • BLMN N/A
  • Revenue
  • XERS $222,551,000.00
  • BLMN $3,930,996,000.00
  • Revenue This Year
  • XERS $35.03
  • BLMN $1.28
  • Revenue Next Year
  • XERS $18.31
  • BLMN $1.55
  • P/E Ratio
  • XERS N/A
  • BLMN $9.92
  • Revenue Growth
  • XERS 29.88
  • BLMN N/A
  • 52 Week Low
  • XERS $2.03
  • BLMN $6.09
  • 52 Week High
  • XERS $6.07
  • BLMN $21.45
  • Technical
  • Relative Strength Index (RSI)
  • XERS 46.97
  • BLMN 62.16
  • Support Level
  • XERS $4.30
  • BLMN $8.90
  • Resistance Level
  • XERS $4.79
  • BLMN $9.65
  • Average True Range (ATR)
  • XERS 0.23
  • BLMN 0.54
  • MACD
  • XERS -0.01
  • BLMN 0.17
  • Stochastic Oscillator
  • XERS 25.93
  • BLMN 93.99

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: